Related Experiment Video
Updated: Nov 18, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801
Angela Wahl1,2,3, Lisa E Gralinski4, Claire E Johnson1,2,3
1International Center for the Advancement of Translational Science, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Bats harbor coronaviruses capable of direct human transmission. A novel mouse model with human lung tissue efficiently replicates SARS-CoV-2, showing the antiviral EIDD-2801
Area of Science:
- Virology
- Infectious Diseases
- Immunology
Background:
- Coronaviruses, including SARS-CoV, MERS-CoV, and SARS-CoV-2, often originate in bats.
- Bats host diverse coronaviruses with pandemic potential.
Purpose of the Study:
- To establish an experimental platform for studying in vivo coronavirus replication in human lung tissue.
- To investigate the potential for direct bat coronavirus transmission to humans.
- To evaluate therapeutic strategies for COVID-19.
Main Methods:
- Utilized immunodeficient mice implanted with human lung tissue (human lung-only mice, LoM).
- Inoculated LoM with SARS-CoV, MERS-CoV, SARS-CoV-2, and bat-derived SARS-like coronaviruses.
- Analyzed viral replication, cytopathic effects, and host immune responses in human lung tissue.
- Assessed the efficacy of EIDD-2801 for therapeutic and prophylactic treatment of SARS-CoV-2 infection.
Main Results:
- The LoM model demonstrated efficient in vivo replication of multiple human and bat coronaviruses without host or viral adaptation.
- SARS-CoV-2 predominantly infected human lung epithelial cells, including type-2 pneumocytes and ciliated airway cells.
- Infection induced significant cytopathic effects and a strong type-I interferon and inflammatory response.
- Administration of EIDD-2801 markedly inhibited SARS-CoV-2 replication in vivo.
Conclusions:
- Bats harbor endogenous coronaviruses capable of direct human transmission.
- The LoM model is a valuable platform for studying human lung infections by emerging coronaviruses.
- EIDD-2801 shows significant potential for preventing and treating COVID-19.
Related Concept Videos
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...

